Alcami Overview
- Year Founded
-
1979

- Status
-
Private
- Employees
-
1,050

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
10
- Investments
-
5
Alcami General Information
Description
Operator of contract development and manufacturing organization (CDMO) intended for small and mid-sized pharmaceutical and biotechnology companies. The company offers formulation and analytical development, testing, microbial identification, stability storage, and other laboratory-related services, enabling clients to avail of a less-fragmented, cost-effective, and faster pathway for product commercialization.
Contact Information
Website
www.alcami.comCorporate Office
- 2320 Scientific Park Drive
- Wilmington, NC 28405
- United States
Corporate Office
- 2320 Scientific Park Drive
- Wilmington, NC 28405
- United States
Alcami Timeline
Alcami Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Alcami Comparisons
Industry
Financing
Details
Alcami Competitors (20)
One of Alcami’s 20 competitors is Recipharm, a Private Equity-Backed company based in Stockholm, Sweden.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Recipharm | Private Equity-Backed | Stockholm, Sweden | ||||
CoreRx | Private Equity-Backed | Clearwater, FL | ||||
Catalent | Private Equity-Backed | NJ | ||||
Curia | Private Equity-Backed | Albany, NY | ||||
Pnp Pharmaceuticals | Private Equity-Backed | Burnaby, Canada |
Alcami Patents
Alcami Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11642324-B1 | Topical tranexamic acid compositions and methods of use thereof | Active | 01-Mar-2022 | ||
US-20240415794-A1 | Topical tranexamic acid compositions and methods of use thereof | Pending | 01-Mar-2022 | ||
US-20220227692-A1 | Compositions and methods of making ribitol | Active | 28-May-2019 | ||
US-12252463-B2 | Compositions and methods of making ribitol | Active | 28-May-2019 | ||
US-20220033352-A1 | Synthetic method for the preparation of an alkoxymethylene-benzoylacetonitrile | Inactive | 26-Sep-2018 | C07C253/30 |
Alcami Signals
Alcami Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Alcami Investments (5)
Alcami’s most recent deal was a Buyout/LBO with Pacific Pharmaceutical Services. The deal was made on 17-Jan-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Pacific Pharmaceutical Services | 17-Jan-2024 | Buyout/LBO | Logistics | ||
Masy Bioservices | 15-Dec-2021 | Buyout/LBO | Laboratory Services (Healthcare) | ||
TriPharm Services | 17-Jan-2020 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
aaiPharma Inc | 02-Oct-2013 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
Cambridge Major Laboratories Europe | 16-Nov-2007 | Buyout/LBO | Pharmaceuticals |
Alcami Exits (1)
Alcami’s most recent exit was on 16-Nov-2007 from Cambridge Major Laboratories Europe. The exit was categorized as with 2 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Cambridge Major Laboratories Europe | 16-Nov-2007 | Completed |
|
Alcami Affiliates
Subsidiaries (2)
Name | Industry | Location | Year Founded |
---|---|---|---|
Pacific Pharmaceutical Services | Reno, NV | 2009 | |
TriPharm Services | Morrisville, NC | 1994 |
Alcami FAQs
-
When was Alcami founded?
Alcami was founded in 1979.
-
Where is Alcami headquartered?
Alcami is headquartered in Wilmington, NC.
-
What is the size of Alcami?
Alcami has 1,050 total employees.
-
What industry is Alcami in?
Alcami’s primary industry is BPO/Outsource Services.
-
Is Alcami a private or public company?
Alcami is a Private company.
-
What is Alcami’s current revenue?
The current revenue for Alcami is
. -
How much funding has Alcami raised over time?
Alcami has raised $161M.
-
Who are Alcami’s investors?
GHO Capital, Vistria Group, and Ampersand (Massachusetts) have invested in Alcami.
-
Who are Alcami’s competitors?
Recipharm, CoreRx, Catalent, Curia, and Pnp Pharmaceuticals are some of the 20 competitors of Alcami.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »